The clinical information you need, at your fingertips.

Aldosterone synthase inhibitor significantly lowered systolic blood pressure in phase 3 testing among patients already taking multiple antihypertensive drugs. . .

Cancer patients who met with an AI avatar of a physician before their first radiation oncology consultation reported better grasp of treatment, less stress, and higher satisfaction than those given a standard educational video. . .

The most comprehensive, dose-effect meta-analysis to date identifies where five common ADHD medications hit peak benefit and where higher doses stop helping or start causing harm, with separate guidance for children and adults. . .

More patients are arriving with disease that has already spread, a shift seen across every age group, racial and ethnic group, tumor subtype, and in both sexes. . .

Randomized trial found no meaningful pain benefit from 90 days of amoxicillin-clavulanate, even in patients with Modic changes on MRI. . .

An investigational oral therapy targeting airway collapse improved obstructive sleep apnea severity and oxygenation over 26 weeks. . .

Immgolis (golimumab-sldi) and Immgolis Intri are the first interchangeable biosimilars to golimumab products for rheumatoid arthritis and ulcerative colitis. . .

Single dose brought rapid, meaningful relief from moderate-to-severe recurrent depression within days, but after a year the advantage over placebo was gone. . .

Most of what patients shed is fat and relative muscle mass holds up, but proportionally more lean tissue is lost than with diet and exercise interventions. . .